Global pediatric vaccine market size is forecast to grow by USD 10.76 billion during 2019-2023 at a CAGR of over 7%, with conjugate vaccines and others market segment having the largest market share. Pediatric vaccine market analysis indicates growth will be driven by the strong late-stage pipeline and new drug approvals. Pediatric vaccine industry growth will also be impacted by the development of vaccines for unmet medical conditions. The market contains a significant number of monotherapy and combination therapy-based vaccines that are currently under the late stages of development and are expected to get approved during the forecast period. For instance, Pertagen is a recombinant vaccine that is in the registration phase for immunization against pertussis in children aged 11 years and above. These vaccines possess a strong therapeutic potential for the prevention of a large number of infectious diseases and allergies in children. Hence, these products have a fair chance of entering the market during the forecast period. Furthermore, the recently approved vaccines for pediatric health are also driving market growth.

Looking for more information on this market? Request a free sample report http://bit.ly/2Z8HYDm


As per Technavio, the development of vaccines for unmet medical conditions will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global pediatric vaccine market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global pediatric vaccine market: Development of vaccines for unmet medical conditions

There are several unmet medical conditions such as HIV, malaria, tuberculosis, dengue, Ebola, H1N1, H5N1, cancer, and various allergic conditions. Significant advances in molecular biology and computational biology have made it possible to develop novel vaccines based on adjuvants, vectors, nucleic acids, and structure-based antigen design. Moreover, the leading manufacturers, in partnership with government bodies, have initiated the development of innovative vaccines owing to the availability of advanced procedures. Thus, such initiatives are expected to help the overall global pediatric vaccine market during the forecast period.
Global pediatric vaccine market: Segmentation analysis

This market research report segments the global pediatric vaccine market by product (conjugate vaccines and others, live-attenuated vaccines, toxoid vaccines, inactivated vaccines) and geographical regions (North America, Europe, Asia, and ROW).


The North American region led the market in 2018, followed by Europe, Asia, and ROW respectively. However, during the forecast period, the Asian region is expected to register the highest incremental growth due to the increasing prevalence of infectious diseases, rising awareness of immunization, and growing healthcare expenditure on vaccination.

Some of the key topics covered in the report include:

Market Landscape
• Market ecosystem
• Market characteristics
• Market segmentation analysis

Market Sizing
• Market definition
• Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation
• Regional comparison
• Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario